ManagedCareCGM.com Presents: Continuous Glucose Monitoring in Managed Care: Emerging Evidence, Quality Trends, and Policy Implications
Intended Audience: This activity is designed to meet the education needs of managed are pharmacy directors, registered nurses, clinical pharmacists, quality directors and medical directors.
Credit Available: Up to 1.5 credit hours available for nurses (ANCC), pharmacists (ACPE), and physicians (AMA PRA Category 1 Credit™)
Expiration Date: January 31, 2028
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe evolving guideline recommendations for CGM across diabetes populations
- Evaluate clinical, real-world, and economic evidence supporting CGM use
- Assess implications of CGM for HEDIS/Stars performance, coverage decisions, and population health strategies
Expert Faculty
Hannah Berg, PharmD
Associate Director, PDL Strategy
UnitedHealthcare
Jamie Chan, PharmD
President/CEO
Elevare Healthcare Consulting, LLC
Charlie Dragovich
Principal
Stractical Solutions LLC
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP
Co-Director of Endocrine Disorders in Pregnancy
Director of Education and Training in Diabetes Technology
Cleveland Clinic Endocrinology & Metabolism Institute
Jaime Murillo, MD
SVP, CMO, Medical Affairs
UnitedHealthcare
This continuing education activity is supported by an independent educational grant from Dexcom Medical Affairs.